A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
Clinical trial NCT03287869 · COMPLETED
Trial details
- NCT number
- NCT03287869
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-24
- Primary completion
- 2019-07-31
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.